IFN 2022 Recap With the Dementia Chair: Richard Isaacson, MD

WATCH TIME: 3 minutes

“The thing that resonated with me at this conference is that, in a lot of ways, the future of neurology is prevention, and the future of neurology is brain health, and trying to get ahead of things before a chronic neurological condition causes morbidity and mortality harm, or a reduction in quality of life.”

Richard Isaacson, MD, director of the Center for Brain Health and Alzheimer Prevention Clinic at Florida Atlantic University medicine, attended the 2022 International Congress on the Future of Neurology (IFN) annual meeting, held September 23-24, in Manhattan, New York, serving additionally as a co-chair of the meeting. He spoke about the importance of having the conference gather speakers to express their views on what the future holds for the field of neurology, which is the single focus of meeting. The meeting had a single-track structure, allowing the benefited for those who attended to center their attention on each of the speakers without sacrificing one talk for another.

Isaacson also took part in a Medical Crossfire session with Marwan N. Sabbagh, MD, FAAN, professor of neurology at the Barrow Neurological Institute, on the topic of “Monoclonal Antibodies in AD: To Use or Not to Use.” Isaacson mentioned that a takeaway from the conference was that its focus on prevention and the maintenance of brain health as the future of neurology care. In addition, he said that the future of neurology should attempt to stay ahead of things for patients to avoid a reduction in their quality of life because of harm done by disease progression.

In a recent conversation with NeurologyLive^®, Isaacson discussed his time at the 2022 IFN annual meeting. He also mentioned that the experience allowed him to learn more from other researchers to broaden his perspective on the future of neurology.